Sign in to continue:

Thursday, May 7th, 2026

Beijing Tongrentang Announces Correction to 2026 Q1 Financial Report Due to Data Entry Error 1

同仁堂2026年一季报更正公告详解

同仁堂发布2026年第一季度报告更正公告,涉及合并利润表关键数据调整

2026年5月1日,北京同仁堂股份有限公司(600085)发布了关于2026年第一季度报告的更正公告。公司在4月30日已披露一季报,但经复查,发现合并利润表中“六、其他综合收益的税后净额之(一)2.(6)外币财务报表折算差额”科目数据遗漏负号,导致相关数据出现重大变化。现已进行更正,并对相关财务数据进行重新披露。

一、关键更正内容

  • 本次更正主要涉及合并利润表中“外币财务报表折算差额”项目,由于遗漏负号,影响到“其他综合收益的税后净额”以及“综合收益总额”等多项核心数据。
  • 更正前后数据出现大幅变动,归属于母公司所有者的其他综合收益和综合收益总额均大幅下修。

二、更正前后主要财务数据对比

项目 更正前(2026 Q1) 更正后(2026 Q1)
六、其他综合收益的税后净额 4,662,317.93元 -81,750,824.03元
(一)归属于母公司所有者的其他综合收益的税后净额 44,119,611.42元 -42,293,530.54元
2. 外币财务报表折算差额 43,206,570.98元 -43,206,570.98元
七、综合收益总额 621,395,212.89元 534,982,070.93元
(一)归属于母公司所有者的综合收益总额 515,296,359.97元 428,883,218.01元
(二)归属于少数股东的综合收益总额 106,098,852.92元 106,098,852.92元

三、对投资者和股东的重要影响

  • 财报数据大幅修正: 由于外币财务报表折算差额由正调为负,使得其他综合收益和综合收益总额均较原报告大幅减少,显示公司在外币折算环节存在较大的负面影响。
  • 归属于母公司所有者的综合收益总额减少: 由原报告的5.15亿元调整为4.29亿元,减少约8600万元,可能影响市场对公司盈利质量和跨境经营风险的评价。
  • 股价可能承压: 该更正为重大负面信息,反映公司财务数据存在误报风险,或导致投资者短期信心受挫,股价面临一定压力。
  • 公司承诺加强信息披露: 同仁堂董事会表示将进一步加强定期报告编制和审核工作,提升信息披露质量,以维护投资者利益。

四、后续安排

更正后的2026年第一季度报告已同步在上海证券交易所网站(www.sse.com.cn)披露。公司向投资者致歉,并重申将持续改进财报编制和审查流程,防止类似事件再次发生。

五、投资者关注要点

  • 关注公司后续相关财报和公告,尤其是外币业务及信息披露合规性。
  • 密切关注市场对本次财务更正的反应以及可能带来的股价波动。
  • 公司治理和内部控制能力是投资者需要重点考量的风险点。

免责声明: 本文仅为资讯整理与分析,不构成投资建议。投资有风险,请投资者审慎决策。

— English version: Detailed Analysis of Tongrentang’s Q1 2026 Earnings Correction Announcement

Tongrentang Issues Major Correction to Q1 2026 Financial Report Affecting Key Profit Figures

On May 1, 2026, Beijing Tongrentang Co., Ltd. (600085) published a correction to its Q1 2026 report. The company had previously released its quarterly results on April 30, but upon review, discovered a significant error in the consolidated income statement: the “Foreign Currency Translation Adjustment” line item was missing a negative sign, leading to substantial changes in core profit and comprehensive income figures. The corrected data has now been officially released.

1. Key Points of the Correction

  • The correction mainly concerns the consolidated income statement’s “Foreign Currency Translation Adjustment,” which, due to the missing negative sign, has drastically altered both the “Other Comprehensive Income (net of tax)” and “Total Comprehensive Income”.
  • Key profit figures attributable to the parent company have been significantly revised downward.

2. Before-and-After Key Financial Data Comparison

Item Before Correction (Q1 2026) After Correction (Q1 2026)
Other Comprehensive Income (net of tax) 4,662,317.93 RMB -81,750,824.03 RMB
Attributable to Parent: Other Comprehensive Income (net of tax) 44,119,611.42 RMB -42,293,530.54 RMB
Foreign Currency Translation Adjustment 43,206,570.98 RMB -43,206,570.98 RMB
Total Comprehensive Income 621,395,212.89 RMB 534,982,070.93 RMB
Attributable to Parent: Total Comprehensive Income 515,296,359.97 RMB 428,883,218.01 RMB
Attributable to Minority Interests 106,098,852.92 RMB 106,098,852.92 RMB

3. Key Implications for Investors and Shareholders

  • Major Downward Revisions: The translation adjustment changed from a positive to a negative value, significantly reducing both other comprehensive income and total comprehensive income, highlighting considerable negative currency effects.
  • Lower Parent Shareholder Profits: Total comprehensive income attributable to parent shareholders fell from 515 million RMB to 429 million RMB—a reduction of about 86 million RMB, which could affect market perceptions of profit quality and cross-border risk.
  • Potential Share Price Pressure: The revision constitutes a material negative disclosure and could undermine short-term investor confidence, putting downward pressure on the share price.
  • Commitment to Improved Disclosure: Tongrentang’s board pledged to strengthen reporting and review processes to enhance disclosure quality and safeguard investor interests.

4. Next Steps

The corrected Q1 2026 report is available on the Shanghai Stock Exchange website (www.sse.com.cn). The company has apologized to investors and promised to further improve financial reporting and internal review to prevent recurrence.

5. Investor Takeaways

  • Monitor subsequent earnings releases and announcements, especially regarding foreign currency operations and disclosure compliance.
  • Watch for market reaction and potential share price volatility following this correction.
  • Corporate governance and internal controls remain key risk considerations for investors.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investing involves risk. Please make decisions prudently.


View 同仁堂 Historical chart here



中广天择传媒股份有限公司2026年第一季度报告财务数据分析与股东信息披露

中广天择传媒股份有限公司2026年第一季度报告深度解读 中广天择传媒股份有限公司2026年第一季度报告深度解读 一、...

国家电投水电子公司五凌电力并购湖南7个新能源项目股权,交易金额超3.3亿元

电投水电五凌电力并购湖南新能源项目详解 电投水电全资子公司五凌电力并购湖南7个新能源项目,交易金额逾3.3亿元 一、...

Shanghai Zhijiang Biotechnology (688317) 2026 Q1 Report: Revenue Decline, Increased Losses, and Financial Highlights

上海之江生物2026年第一季度财报深度解析:营收下滑与亏损扩大引发关注 上海之江生物2026年第一季度财报深度解析:...

   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today